Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

I am upgrading Japan Tobacco stock from Hold to Buy, after considering its satisfactory 2024 performance and its positive ...

The equity markets in 2025 have been marked by intense volatility, largely driven by geopolitical tensions and renewed trade conflicts. Trump’s aggressive tariff policies have escalated trade disputes ...

Ohio State graduate students seeking professional guidance and networking opportunities can take advantage of various events offered by the university over the next few months. Below is a list of a ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

New polling released this morning by the firm Navigator Research finds that 57 percent of Americans are more concerned that ...

After back-to-back years of 20%-plus gains in 2023 and 2024, the S&P 500 is off to another strong start to 2025. However, the S&P 500's forward earnings multiple of 22 (as of Feb. 7) was also ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Projections indicate that small caps are set to experience significantly higher earnings growth than large caps in 2025.

Even when measured against a more comprehensive list, momentum outdid all of its rivals in 2024 and is shaping up for a repeat in 2025, according to data shared with MarketWatch by Piper Sandler's ...